ARRIS to Present at NASDAQ's 36th Investor Program
Get Alerts ARRS Hot Sheet
Join SI Premium – FREE
SUWANEE, Ga., June 1, 2017 /PRNewswire/ -- ARRIS International plc (NASDAQ: ARRS) a global telecommunications technology leader, today announced that Bruce McClelland, ARRIS Chief Executive Officer, will be speaking at the upcoming NASDAQ Investor Program on Thursday, June 15 at approximately 3:00pm/BST (10:00am EDT). Investors may listen to the webcast live by logging on to
http://edge.media-server.com/m/p/g82t5pf3
This webcast will be archived for 12 months following the live presentation.
About ARRIS
ARRIS International plc. (NASDAQ: ARRS) is a world leader in entertainment and communications technology. Our innovations combine hardware, software, and services across the cloud, network, and home to power TV and Internet for millions of people around the globe. The people of ARRIS collaborate with the world's top service providers, content providers, and retailers to advance the state of our industry and pioneer tomorrow's connected world. For more information, visit www.arris.com.
For the latest ARRIS news: Check out our blog: ARRIS EVERYWHERE Follow us on Twitter: @ARRIS
ARRIS and the ARRIS Logo are trademarks or registered trademarks of ARRIS Enterprises LLC. All other trademarks are the property of their respective owners. © ARRIS Enterprises LLC. 2017. All rights reserved.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/arris-to-present-at-nasdaqs-36th-investor-program-300467175.html
SOURCE ARRIS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma
- Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026
- MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share